While PDIs and TOIs differ in both the way participants are recruited (by peers in PDIs and by outreach workers in TOIs) and in how the intervention is delivered (by peers in PDIs and by outreach workers in TOIs), most comparison studies attribute differences in the intervention outcome solely or primarily to the way in which the interventions are disseminated.
Furthermore, most comparison studies were based merely on chemical stabilities, where thiols, such as dithiothreitol (DTT) or mercaptohexanol (MCH), were used to displace the thiolated DNA from AuNP surfaces.
Most external comparison studies in this group found no elevated SMRs for either IHD or all CVD.
Furthermore, the performance of clustering methods can vary depending on the type of data being analysed [ 13] and most previous comparison studies have been written for a statistical audience rather than for clinical researchers.
It is interesting that most cost comparison studies based on administrative claims data (e.g. private health plans or WC plans) reported that health care costs were generally lower for members/workers whose spine pain was managed with chiropractic care.
Neither is there a standard for describing the exposure atmospheres; the detail with which exposures are characterized varies considerably, and most comparisons among studies are made on the basis of particulate matter (PM) mass concentrations.
In order to circumvent this problem, most validation and comparison studies focus on simulated data in which real or simulated 'artifact-free' data and 'artifactual' data are linearly mixed at some known ratio [11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21].
To determine which carbonaceous nanomaterials have the most severe effect, comparison studies were conducted with the same biological model system.
Most of these comparison studies were confined between AAA and AXB, as both of them are implemented in the same treatment planning system.
In most of these comparison studies, discrepancies found between the different assays were partly explained by the fact that these molecular assays were using different capture technologies for CTC isolation and very different detection systems.
Caseness usually implies the presence of an active headache disorder, which was defined in ICHD-II as characterized by any occurrence of headache (either generally or of the requisite type) during the last year [11]; hence 1-year prevalence is most used, and it allows the most comparisons with previous studies (but see page 4).
